CALIFORNIA NEWSWIRE (LOS ANGELES, Calif.) — ProNova Partners, a 17-year-old Mergers and Acquisitions firm, has announced it has been retained to develop major strategic partnership and acquisition relationships for a breakthrough at-home vision-testing technology built on optical science exclusively licensed from the Massachusetts Institute of Technology (MIT).
The platform lets a person measure their own vision with a smartphone and receive a doctor-generated eyeglass or contact lens prescription remotely, without a clinic visit. It spans seven FDA-registered medical devices and applications, and independent clinical trials have confirmed accuracy comparable to the in-office equipment used in a traditional eye exam.
More than 50,000 devices are in use across over 150 countries, built up over eight years of operation with zero product defects and zero litigation. The technology, while not meant to replace the traditional in-clinic eye exam, carries a full regulatory and quality stack, including ISO 13485 and HIPAA compliance, and is protected by more than two dozen issued patents.
The technology arrives as the roughly $60-billion U.S. vision-care market faces a growing shortage of eye-care providers, and as the traditional eye exam – essentially unchanged for two centuries – becomes the next consumer-health category reshaped by telehealth and artificial intelligence.
Company details are available to qualified parties upon execution of a standard non-disclosure agreement.
For detailed information go to https://pronovapartners.com/engagement/patented-at-home-vision-testing-platform-for-sale/
* * *
This version of news first appeared on CaliforniaNewswire.com © 2026 – all rights reserved.
